homocysteine has been researched along with Foramen Ovale, Patent in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conte, L; Mazza, A; Rigatelli, A; Rigatelli, G; Ronco, F; Roncon, L; Zuin, M | 1 |
| O'Suilleabhain, P | 1 |
| Buonanno, FS; Deng, W; Inglessis-Azuaje, I; Lo, EH; Locascio, JJ; McMullin, D; Ning, M; Palacios, IF | 1 |
| Dias, B; Munoz, C; Ozdemir, AO; Spence, JD; Tamayo, A | 1 |
| Aggio, S; Chinaglia, M; Grassetto, G; L'Erario, R; Mazza, A; Montemurro, D; Pastore, G; Piergentili, C; Rubello, D; Zamboni, S; Zanier, A; Zanon, F | 1 |
5 other study(ies) available for homocysteine and Foramen Ovale, Patent
| Article | Year |
|---|---|
Correlations between serum homocysteine levels and RoPE score in patients with patent foramen ovale.
Topics: Adolescent; Adult; Biomarkers; Clinical Decision Rules; Embolism, Paradoxical; Female; Foramen Ovale, Patent; Homocysteine; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Young Adult | 2020 |
Yet Another Way to Lower Homocysteine: Close the Patent Foramen Ovale.
Topics: Foramen Ovale, Patent; Homocysteine; Humans; Stroke | 2021 |
Effect of Patent Foramen Ovale Closure After Stroke on Circulatory Biomarkers.
Topics: Adult; Biomarkers; Female; Foramen Ovale, Patent; Homocysteine; Humans; Male; Mass Spectrometry; Middle Aged; Prospective Studies; Stroke | 2021 |
Cryptogenic stroke and patent foramen ovale: clinical clues to paradoxical embolism.
Topics: Adult; Blood Coagulation Tests; Embolism, Paradoxical; Female; Foramen Ovale, Patent; Homocysteine; Humans; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Stroke; Ultrasonography, Doppler, Transcranial; Vitamin B 12 | 2008 |
Could genetic analysis be useful in reducing cerebrovascular risk in hypertensive subjects with hyperhomocysteinemia and patent foramen ovale? A 2-year follow-up study.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Blood Pressure; Cerebrovascular Disorders; Chi-Square Distribution; Echocardiography, Transesophageal; Female; Folic Acid; Follow-Up Studies; Foramen Ovale, Patent; Gene Frequency; Genetic Predisposition to Disease; Heterozygote; Homocysteine; Homozygote; Humans; Hyperhomocysteinemia; Hypertension; Italy; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Mutation; Polymorphism, Genetic; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vitamins; Young Adult | 2010 |